Marion Dorsch, Chief Scientific Officer at Blueprint Medicines Corp (BPMC), sold 35,668 shares at $65.16 ($2.3M) on 2017-11-21, disclosed to the SEC on 2017-11-22.
Open-market sale of $2.3M BPMC by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $65.16 | 11,483 | $748K | 32.0% |
| 2 | $65.16 | 11,483 | $748K | 32.0% |
| 3 | $65.81 | 4,750 | $313K | 13.4% |
| 4 | $65.81 | 4,750 | $313K | 13.4% |
| 5 | $66.81 | 1,601 | $107K | 4.6% |
| 6 | $66.81 | 1,601 |
| $107K |
| 4.6% |
| Total | $65.48 avg | 35,668 | $2.3M | 100% |
| Filing → |
| BPMC | SELL | 2020-10-08 | $455K | — | Filing → |
| BPMC | SELL | 2020-09-25 | $409K | — | Filing → |
| BPMC | SELL | 2020-06-23 | $363K | — | Filing → |